Ruti Aga: The six-year ban came from a prescription no clinic ever wrote, not from the injection
**मुख्य उत्तर** इथियोपियाई मैराथन धाविका रुती अगा को छह साल का प्रतिबंध मिला — दो साल मिथाइलप्रेडनिसोलोन की उपस्थिति के लिए और चार साल जाली पर्चा पेश करने पर छेड़छाड़ के लिए। सज़ा 10 सितंबर से प्रभावी है, जो उनके अनंतिम निलंबन की तारीख़ है। **मुख्य तथ्य** - मिथाइलप्रेडनिसोलोन ग्लूकोकॉर्टिकॉइड है, WADA सूची का वर्ग S9; केवल प्रतियोगिता-अवधि में प्रतिबंधित, एनाबॉलिक स्टेरॉयड नहीं। - पॉज़िटिव नमूना मार्च में चीन की एक आधी मैराथन जीतने के बाद लिया गया था। - पर्चा परिवार के एक सदस्य ने लिखा, जिसका कोई मेडिकल पंजीकरण नहीं था। - जिस क्लिनिक के नाम पर पर्चा था, उसने कहा कि उसने ऐसा दस्तावेज़ जारी नहीं किया। - अगा ने 2019 की टोक्यो मैराथन जीती थी और तीन वर्ल्ड मैराथन मेजर्स में दूसरा स्थान पाया था। **स्रोत** Athletics Integrity Unit (AIU) की आधिकारिक विज्ञप्ति, गुरुवार को जारी; विज्ञप्ति की सटीक प्रकाशन तिथि और वर्ष स्रोत में अपुष्ट। WADA प्रतिबंधित सूची (वर्ग S9) और विश्व एथलेटिक्स डोप-विरोधी नियम, 2021 WADA कोड का संदर्भ। **संबंधित प्रश्नोत्तर** प्रश्न: छह साल की सज़ा कैसे बनी? उत्तर: उपस्थिति उल्लंघन के दो साल और छेड़छाड़ के मानक चार साल मिलाकर, बिना किसी महत्वपूर्ण राहत के। प्रश्न: क्या घुटने का इंजेक्शन वैध हो सकता था? उत्तर: हाँ — प्रतियोगिता से बाहर लगाया गया चिकित्सकीय ग्लूकोकॉर्टिकॉइड इंजेक्शन वैध है, बशर्ते असली मेडिकल रिकॉर्ड हों और प्रतियोगिता-अवधि में अवशेष न बचे। प्रश्न: 2019 की टोक्यो जीत रद्द होगी? उत्तर: अपने आप नहीं; रद्दीकरण का दायरा AIU की विज्ञप्ति में नहीं बताया गया है।
A half marathon in March. In China. No name in the source, no time, no weather, no field depth. Only that Ruti Aga won it, and that the sample she gave afterwards came back positive. The real story in the Athletics Integrity Unit's Thursday statement is not in that sample. It is in the piece of paper produced later — a prescription brought forward by a family member described as a doctor, who held no medical registration, who said he had used "an old prescription pad from a former workplace," and whose named clinic stated plainly that it had never issued any such document.

Three separate verifications, all three failed. That is why the sanction reads six years and not two: two years for presence of a prohibited substance, four for tampering. Both run from 10 September, the date her provisional suspension began.
A technical correction is necessary here, because the first wave of reporting repeated an error. Methylprednisolone was described as a "prohibited steroid" and as "classed as performance enhancing by WADA." It is a glucocorticoid — class S9 on the WADA Prohibited List — not an anabolic steroid, which is class S1. Under the current List, S9 substances are prohibited in-competition only, and only by injection, oral or rectal route. A therapeutic knee injection given out of competition is entirely lawful. It becomes a violation when residues are still present in-competition.
That single sentence turns the case. Which is why, before being surprised by six years, a reader should understand that the paper built this sanction, not the drug.
Aga is 32, out of the Ethiopian generation that moved women's marathoning onto another planet. Her record carries the 2026 Tokyo Marathon title and three second places at World Marathon Majors. My own notebooks hold 2:18:34 from Berlin 2026 (second) and 2:20:40 from Tokyo 2026 (first); the source does not confirm those figures, so I keep them as context, not as claim. The AIU statement gives no personal best, no splits, no field strength.

I watched that Tokyo race on a screen in London, at an hour I would rather not repeat. What stayed in the notebook was not the finish time but the composure of the second half. Marathons are joint stories, and joint stories never end at the finish line.
Ethiopian women's marathon depth is such that a 2:18 performer cannot assume selection. Which is why one 32-year-old stepping away for six years moves not a single number in Ethiopian selection arithmetic. What does move is the place the case was filed — the Chinese label-race circuit, where large appearance-fee budgets, deep East African elite fields and AIU testing meet in the same race.
That circuit is familiar to me under a different name. In India I never measured an athlete's season in contracts. I measured it in leave sanctioned, camp days at Patiala, and the gaps in a federation calendar. In East African road running the same economy wears appearance fees and agent-run camps. In both places one thing is missing: a medical system that exists on paper.
The knee, the injection, and a window that opens at 23:59
According to the source, Aga cited a knee injury — the reason methylprednisolone enters the record. Intra-articular or peri-articular glucocorticoid injection for knee synovitis is ordinary sports-medicine practice in distance runners, and I want to be careful that saying so is not a diagnosis. I am only saying the mechanism holds.
But in road racing, mechanism and law are two different clocks. The in-competition period does not begin when the gun fires. In road races it is generally taken to open at 23:59 the night before the race. An injection given three days out, if residues remain on race day, becomes a violation. Washout varies by route; my figures there are unverified, so I will not print them as numbers. What is settled: the question is not whether a drug was taken, but when, by which route, and in whose records.
The scan said clean; the warm-up said otherwise. I keep both. In this case the scan is the prescription and the warm-up is the injection record. When the two disagree, a reporter should not silently let one beat the other. I have to write here that I do not know what the knee diagnosis actually was, or who gave the injection, or where, or by which route. The AIU statement does not answer those questions. Where the archive is silent, I write the silence.
The defence that was available, and the one that was not
If the treatment was genuine, the defence was straightforward: the clinic's real note, the date and route of the injection, the name of a registered physician, and a therapeutic use exemption application if the injection fell inside the competition window. With those four documents the case could have landed at the no-fault or no-significant-fault end, where the sanction can shrink to a reprimand. And the tampering charge would not exist at all.
What carried this case to six years was not the drug but the attempt to manufacture proof of the drug. A real treatment is defended with real paper. An athlete with no paper to fight with fabricates paper, and that is where the sport ends for her.
The three verification failures deserve to be read in sequence. The prescription was written by a family member with no medical registration. He claimed an old prescription pad from a former workplace. The clinic named on the document denied issuing it. Any one of those holding would have left the case at two years.
And what adds the four
Tampering carries a standard four-year sanction under the Code, and here the charge rests not on a document alone but on an interview — on statements made under questioning. That detail looks small and is not. AIU interviews with East African road runners take place under language and translation conditions that have been a recurring point of contention. I am not claiming translation played a role in this case. I am saying that when a large share of a sanction rests on spoken words, the conditions of those words belong in the record.
The arithmetic is legible. Two plus four is six, and the sum carries information: had the panel accepted any substantial mitigation on presence, the number would not be six. It found the substance present and the concealment culpable.
Backdating to 10 September is not leniency. Provisional suspension time counts against the ban, so the athlete recovers only the months she had already served. Reading it as a concession is a common error.
What is annulled, and what is not
The AIU statement does not state the scope of disqualification. The March result and its prize money are very likely void, since the competition at which the sample was collected is automatically disqualified. Ranking points accrued after that date should go as well. The 2026 Tokyo title does not fall automatically; earlier results are annulled only on a finding of earlier use, and nothing of the kind is public here. I am recording that the source is silent on scope. I will not convert inference into fact.
Career arithmetic
Six years from 32 means a return at roughly 38. Thirty-eight is not an impossible marathon age. In Ethiopian women's marathoning, a 38-year-old with a doping record is not a selection any federation will make. The ban is six years on paper and a career on the ground.
Commercially the picture has split in two. On one side, the 2026 Tokyo title and three Major podiums remain the record of a genuinely elite marathoner, and will remain. On the other, distance-running sponsorship is already thin, and a doping case makes it close to zero. Both facts are true and belong in the same paragraph.
Camps, club doctors, and an economy that never reaches paper
If this were one athlete's mistake, six paragraphs would cover it. What shows here is a structure. There is no team physician in the statement, no clinic, no TUE process. What exists is a relative acting as doctor and an old pad. That is not a filing error; it is the signature of an absent medical system.
I write from London, and the limit applies to me: what I have not seen in camps at Iten or Addis Ababa, I will not write as though I saw. What I do know is that the road-racing economy rewards appearing, not being fit. Running on a sore knee can be financially rational. Glucocorticoids are the cheapest, most available tool for switching that pain off for a fortnight.
Load is a story told in minutes, and I only transcribe it. Here load wears a knee, and the knee wears an injection with no real record. I ask the physio first, the coach second, and I write in that order. No physio is named anywhere in this case. That is the largest fact in it, and it will not reach a headline.
The angle that is not convenient
Six years landed on a substance with no established endurance benefit. A glucocorticoid reduces pain and swelling; it does not add speed. Procedurally the outcome may be correct and substantively it looks disproportionate — especially because the first coverage called it a steroid, which summons anabolic cases in the reader's mind and makes six years feel proportionate. The comparison is false, and consent built on a false comparison is dangerous.
The more important shift is that the enforcement frontier has moved from detection to document verification. Once presence cases became provable, the contested ground became paperwork. The three failed verifications here are not one athlete's story; they belong to a category in which an initial substance violation is compounded by a fabricated explanation.
And the hardest angle. The knee explanation is mechanistically credible enough that its credibility is what made the forgery fatal. A genuine treatment produces genuine records and no case at all. Plausibility and verifiability are different things, and conflating them is the commonest error in sports-medicine journalism. I will not retro-diagnose her knee. I will say that what was documented at the time could not establish treatment, and that what was produced later was found to be false.
A legal route remains. A CAS appeal window, typically about 21 days from the reasoned decision, exists; a document-based tampering finding is hard to overturn. One element sits outside AIU jurisdiction entirely: document forgery can be a criminal matter, and referral to national authorities is possible. The source does not say whether that happened.
Forward
No statement from the Ethiopian federation appears in the source. Only the AIU. That silence is itself a signal about where this case sits in the national system's priorities.
For anyone treating this as an isolated file, one question. When a camp has no registered doctor, when an athlete has nowhere to record the date of an injection, when the TUE process sits so far away that an old prescription pad looks simpler — who writes the prescription? Whoever stands closest writes it. Unless a system decides who stands closest, the next case begins on the same old pad.
Return-to-run is a series of small permissions — a run, a scan, a week. Six years has broken that sequence entirely. The question is not whether the sanction was harsh. The question is whether, had that knee been documented properly on one sheet of paper, any of us would be writing this at all.
